Pricing Log in Create free account

Compass Therapeutics, Inc. (CMPX) vs Precision BioSciences, Inc. (DTIL)

Compass Therapeutics, Inc. and Precision BioSciences, Inc. are both Biotechnology companies. Compass Therapeutics, Inc. and Precision BioSciences, Inc. are of similar size ($170.3M and $161.5M). Across the 10 metrics below, Compass Therapeutics, Inc. leads on 5 and Precision BioSciences, Inc. on 5.

Valuation

Metric CMPX DTIL Biotechnology median
P/E n/m n/m 8.50
P/S n/m 3.31 9.71
P/B 0.97 3.29 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.17 n/m 0.64
EV/Sales n/m 1.87 9.21
Earnings yield (46.51%) (48.35%) (33.15%)
Free cash flow yield (35.09%) (35.07%) (25.50%)

Profitability

Metric CMPX DTIL Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.66%) (132.91%) (56.36%)
Return on assets (47.87%) (44.91%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CMPX DTIL Biotechnology median
Revenue growth (TTM) — (11.87%) 6.02%
EPS growth (last fiscal year) (16.67%) (442.31%) 30.26%
Revenue growth, 5-year CAGR — 7.13% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMPX DTIL Biotechnology median
Debt to equity 0.00 0.50 0.00
Current ratio 11.22 12.82 4.72
Net debt to EBITDA 2.86 1.86 0.96

Dividend

Metric CMPX DTIL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CMPX DTIL Biotechnology median
Market cap 161.49m 170.30m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack